124 results
Page 3 of 7
8-K
EX-99.1
n9bejlbh8l0g0
5 Aug 21
Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2021 Financial Results
4:14pm
8-K
EX-99.1
hxsbiztzsjmrjg4etukw
28 Jun 21
Other Events
6:07am
8-K
zepv4relxb eyvcqra6q
28 Jun 21
Other Events
6:07am
8-K
EX-99.1
z6xtz grizh5
27 May 21
GSK and Vir Biotechnology Announce Sotrovimab (VIR-7831) Receives
4:55pm
8-K
EX-99.2
lkagm7evnmm3s m4mrb
27 May 21
GSK and Vir Biotechnology Announce Sotrovimab (VIR-7831) Receives
4:55pm
8-K
rfv1l
27 May 21
GSK and Vir Biotechnology Announce Sotrovimab (VIR-7831) Receives
4:55pm
8-K
ib4y5w bhw8
24 May 21
Entry into a Material Definitive Agreement
5:00pm
8-K
EX-99.1
s4g5gt2fitbu 74
21 May 21
CORRECTION — EMA Issues Positive Scientific Opinion on GSK and Vir Biotechnology’s
3:38pm
8-K
EX-99.1
fbm0a tvt5ycw6nh36s6
6 May 21
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2021 Financial Results
4:24pm
8-K
EX-99.1
i11wwou8qrv
13 Apr 21
Other Events
4:06pm
8-K
EX-99.1
5tnf21 mh3p9laxa6nc
25 Feb 21
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2020 Financial Results
4:15pm
8-K
q4b7tor8heu48 0c
19 Feb 21
GSK and Vir Biotechnology Expand Coronavirus Collaboration to Advance New Therapeutics for Influenza and Other Respiratory Viruses
5:03pm
8-K
EX-99.1
h2pl0e6
19 Feb 21
GSK and Vir Biotechnology Expand Coronavirus Collaboration to Advance New Therapeutics for Influenza and Other Respiratory Viruses
5:03pm
8-K
EX-99.1
j7amlxoa59wi9xrbvi
28 Jan 21
Other Events
4:05pm
8-K
EX-99.2
omoip0entueuctl040w8
28 Jan 21
Other Events
4:05pm